Viewing data from:

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

ANDA

CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE | A214065 | ALKEM LABORATORIES LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: LIBRAX(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.2692

per ea

Lowest NADAC/Unit

$0.2692

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
67877073101CHLORDIAZEPOXIDE-CLIDINIUM CAP	$0.2692	EA	Generic	—	2026-06-17
60687063994CHLORDIAZEPOXIDE-CLIDINIUM CAP	$0.2692	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 1 NDC (1 FSS)

Lowest Price

$26.06

Highest Price

$26.06

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
67877-0731-01CHLORDIAZEPOXIDE HCL 5MG/CLIDINIUM BR 2.5MG C	$26.06	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jan 12, 2021	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 5MG;2.5MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Apr 26, 2021

No patent or exclusivity listings for this strength.